📊 Score Breakdown
Offering Ability
20
Cash Runway
85
Float Risk
47
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
41%
🔄 Reverse Split
45%
• 50-day avg $1.43 approaching $1 threshold
• Only 4 months cash — financial pressure
📉 Score Deterioration
40%
• Score rose 26 points recently (worsening)
💰 Capital Raise
35%
• Low cash runway: 4 months remaining
💹 Market Data
Market Cap$19.69M
Shares Outstanding13.97M
Float5.83M
Cash$140.0K
Debt$2.23M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 2.0% shares (2025Q4 vs prior)
10 institutional holders · 149.4K shares
#1
MORGAN STANLEY
35.7K shares
#2
SHUFRO ROSE & CO LLC
31.3K shares
#3
CITADEL ADVISORS LLC
23.9K shares
+ 7 more holders Sign up free to view →
📉 Short Interest
Short Interest10.6K
Days to Cover1.1
% of Float0.2%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2025
xbrl
XBRL CONVERTIBLE
Dec 31, 2025
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for EQS
📊 EQS FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 EQS Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.